Building the regulatory file for gamma-oryzanol
This page cannot tell a buyer that γ-oryzanol is cleared in a given market, and it does not try. What it can do is set out the instruments that apply, the limits the file has to demonstrate, and the documents a reviewer will ask for. The route itself — food, supplement, novel food or another category — is confirmed by the buyer's regulatory team for the destination, because it turns on the material's history and the finished product, not on the specification alone.
The certificate describes one lot; the regulatory file shows how the destination classifies the material, which limits apply and how the label must read.
The four questions a reviewer asks
Every regulatory file is an answer to four questions, and different documents answer them. What is the substance, and which version of the specification governs it? Which lot is in the shipment, and what did its certificate measure? What limits and labelling rules apply to the finished product in the destination? What happens to the file if the source, process or pack changes?
The certificate answers the second question and the technical data sheet the first. Neither addresses the third. A folder of PDFs is hard to review; a file with an index, a version beside each document and a named owner is easy to review.
European Union
Three layers apply at once. General food law, Regulation (EC) No 178/2002, sets the safety obligation; labelling follows Regulation (EU) No 1169/2011; contaminant maximum levels sit in Regulation (EU) 2023/915, which replaced the earlier contaminants regulation. Each is amended from time to time, so the current consolidated text is the reference.
Whether the material needs a novel-food authorisation under Regulation (EU) 2015/2283 is a separate question. It turns on the evidence of use in the Union before the cut-off date, and the buyer's team establishes that position for the destination and records it in the file. A supplier's specification does not settle it, and this page does not assert it.
Great Britain and Northern Ireland do not follow one rulebook. The GB file uses the GB register and GB labelling; Northern Ireland follows the EU framework. The destination decides which file is built.
United States
For a dietary supplement the material is a dietary ingredient, and the finished product is made under the cGMP rule at 21 CFR 111. If the ingredient was not marketed in the United States before 15 October 1994, a new dietary ingredient notification under 21 CFR 190.6 may be needed; a structure/function claim carries its own notification duty under 21 CFR 101.93.
The supplier's part is to state the basis it relies on and supply the document behind it. The buyer's part is to confirm that the basis reaches the finished product and the wording on the label. A certificate is evidence about a lot, not about a market.
Contaminants
The catalog limits describe the ingredient; the finished product has to meet its own limits after the dose is applied. That conversion is the step most often left out of a file.
| Metal | Catalog limit on the ingredient | Evidence the file needs |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Lot figure, method and the dose calculation |
| Arsenic (As) | ≤2 mg/kg | Lot figure and method |
| Cadmium (Cd) | ≤1 mg/kg | Lot figure, and any category exception |
| Mercury (Hg) | ≤0.1 mg/kg | Lot figure and method |
Each element needs its own number. A combined figure cannot be compared with a limit written per metal, and a “not detected” without a detection limit says more about the method than about the sample.
Claims
A name is not a claim, and a certificate is not a claim review. Any statement that ties the ingredient to a health outcome or a disease state is assessed against the destination's rules, and the reviewer confirms whether an authorised wording exists or a notification is required. Structure/function wording has its own conditions and is not a substitute for an authorised health claim.
No disease-related claim is made for this material. The label should name the ingredient in the form the file covers — γ-oryzanol for the ester mixture, ferulic acid only where the free acid is what is weighed. Whether a conversion may appear in the ingredient statement is a labelling decision for the destination, not an arithmetic one for the supplier.
The document set
| Document | Why the reviewer asks for it | Version control |
|---|---|---|
| Specification | Defines what is bought | Revision and date |
| Certificate of analysis | Shows the lot result | Lot code and release date |
| Technical data sheet | Properties, solubility, handling | Matched to the specification |
| Safety data sheet | Hazards and first aid | Current revision |
| Origin statement | Rice bran and country of origin | Per lot |
| Allergen and GMO statements | What the source carries | Per source |
| Residual solvent statement | What extraction leaves behind | Per process |
| Stability summary | Retest period for the pack | Per pack and condition |
If a statement is missing for a lot, say so before the shipment rather than at the border. The gap is easier to close at the factory than at customs.
Before the first order
- Specification revision, CAS number and rice-bran origin are stated.
- Certificate, technical data sheet, safety data sheet and the origin, allergen, GMO and solvent statements are present.
- Each metal result has been converted to the finished-product dose.
- Label wording and claim wording have been reviewed for the destination.
- Source, process and pack sit under change control.
- Quotation, specification and certificate carry the same version.
Specification values are on the product hub; the certificate is explained on the COA page; the analytical evidence is on the identity page; the release file is described on the quality page; framework references are in the EU regulatory notes.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation